LAS VEGAS, April 11, 2014 /PRNewswire/ — The International Society for CNS Drug Development (ISCDD) has announced that Dr. John H. Greist was the recipient of the 2014 ISCDD Award at its 12th Annual Meeting.
The 2014 ISCDD Award was presented to Dr. Greist by Dr. Bill Potter, the current Chairman of the ISCDD Executive Committee, and Dr. George Garibaldi, the Chairman-Elect.
Dr. Potter and Dr. Garibaldi discussed Dr. Griest's long career and commented that it was very appropriate that Dr. Griest receives the ISCDD prize this year, as his many contributions include the use of novel technologies in clinical trials, the main focus of the 2014 ISCDD Annual Meeting.
Dr. Greist is a founding member of ISCDD and past Chairman of the Executive Committee. He is a Distinguished Senior Scientist at the Madison Institute of Medicine, and well known for his contributions to improving CNS clinical trial methodology over many decades.
The International Society for CNS Drug Development (ISCDD) was formed in 2002 with the goal of establishing a forum for improvement of methodology in CNS research. ISCDD is a non-profit independent society focused on addressing scientific challenges in CNS drug development, through research and collaboration among stakeholders including academia, industry and government.
For more information, please contact:
ISCDD Secretariat
Erica Moore
702-992-0784
Email